LIMN CIK: 1971387

Liminatus Pharma, Inc.

  • United States
  • Healthcare
  • Biotech
Metrics score locked — part of Premium
FY24
FY25
FY24 – FY25

Assets

(positive)
Change from FY24 to FY25
millions USD
FY24:
5.28
FY25:
0.50
(positive)
Change from FY24 to FY25
millions USD
FY24:
0.13
FY25:
0.01
Total assets
Change from FY24 to FY25
millions USD
FY24:
5.41
FY25:
0.51

Liabilities & Equity

(negative)
Change from FY24 to FY25
millions USD
FY24:
24.7
FY25:
10.3
(negative)
millions USD
FY24:
0
FY25:
0.03
(positive)
Change from FY24 to FY25
millions USD
FY24:
−19.3
FY25:
−9.81
Total liabilities & equity
Change from FY24 to FY25
millions USD
FY24:
5.41
FY25:
0.51

All amounts in millions USD Data sources:SEC EDGARTwelve Data